中文名 | Rocaglamide |
英文名 | Rocaglamide |
别名 | 楝酰胺 洛克米兰酰胺 (1R,2R,3S,3AR,8BS)-1,8B-二羟基-6,8-二甲氧基-3A-(4-甲氧基苯基)-N,N-二甲基-3-苯基-2,3,3A,8B-四氢-1H-环戊二烯并[B]苯并呋喃-2-甲酰胺 |
英文别名 | NSC 326408 Rocaglamide ROCAGLAMIDE 2,3,3a,8b-Tetrahydro-N,N-dimethyl-1α,8bβ-dihydroxy-6,8-dimethoxy-3β-phenyl-3aβ-(4-methoxyphenyl)-1H-cyclopenta[b]benzofuran-2α-carboxamide N,N-Dimethyl-1α,8bβ-dihydroxy-6,8-dimethoxy-3β-phenyl-3aβ-(4-methoxyphenyl)-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-2α-carboxamide 2,3,3a,8b-Tetrahydro-1α,8bβ-dihydroxy-6,8-dimethoxy-3aβ-(4-methoxyphenyl)-N,N-dimethyl-3β-phenyl-1H-cyclopenta[b]benzofuran-2α-carboxamide (1R)-N,N-Dimethyl-1α,8bβ-dihydroxy-3β-phenyl-3aβ-(4-methoxyphenyl)-6,8-dimethoxy-2,3,3a,8b-tetrahydro-1H-cyclopenta[b]benzofuran-2α-carboxamide (1R)-2,3,3a,8b-Tetrahydro-1α,8bβ-dihydroxy-6,8-dimethoxy-3aβ-(4-methoxyphenyl)-N,N-dimethyl-3β-phenyl-1H-cyclopenta[b]benzofuran-2α-carboxamide (1R,2R,3S,3aR,8bS)-2,3,3a,8b-Tetrahydro-1,8b-dihydroxy-6,8-dimethoxy-3a-(4-methoxyphenyl)-N,N-dimethyl-3-phenyl-1H-cyclopenta[b]benzofuran-2-carboxamide |
CAS | 84573-16-0 |
化学式 | C29H31NO7 |
分子量 | 505.56 |
密度 | 1.321±0.06 g/cm3(Predicted) |
熔点 | 117-118 °C |
沸点 | 667.3±55.0 °C(Predicted) |
溶解度 | 溶于DMSO或乙醇 |
酸度系数 | 11.70±0.70(Predicted) |
存储条件 | -20°C |
稳定性 | 从提供的购买之日起稳定2年。DMSO或乙醇中的溶液可以在-20 °C下储存长达1个月。防止暴露在光线和湿气中。 |
外观 | 胶卷 |
颜色 | colorless |
体外研究 | Rocaglamide enhances TRAIL-induced apoptosis in resistant HCC cells. Treatment with Rocaglamide alone leads to apoptosis in 9% HepG2 and 11% Huh-7 cells and treatment with TRAIL induces apoptosis in 16% HepG2 and 17% Huh-7 cells. However, the combination of Rocaglamide and TRAIL induces apoptosis in 55% HepG2 and 57% Huh-7 cells, which is evidently more than an additive effect. A similar result is obtained by measurement of cell viability using crystal violet staining. Rocaglamide has the potential to sensitize highly chemoresistant HepG2 and Huh-7 cells to TRAIL-based therapy. |
体内研究 | Tumor volumes in the Rocaglamide-treated group are 45±12% compared with the control group. Rocaglamide significantly suppresses tumor growth compared with that in the control group. Treatment with Rocaglamide does not lead to any reduction in body weight and no apparent signs of toxicity are observed in the mice during the treatment, suggesting that Rocaglamide is generally tolerated well. |
WGK Germany | 3 |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!